The photocatalytic CO2 reduction into value‐added chemicals is regarded as one promising technology to mitigate environmental issues and the energy crisis of the modern world due to the extended CO2 emissions. Recent advances have shown that iron porphyrins are considered as one of the most efficient molecular catalysts in the activation and reduction of molecules like CO2. Thus, a suitably modified FeIII porphyrin ([FeIII(TF4TMAP)](CF3SO3)5) was prepared and its catalytic activity in terms of photocatalytic reduction of CO2 was studied. This iron catalyst possesses four fluorine substituents in the ortho and the meta position of each meso‐phenyl group of the porphyrin, while trimethylammonium groups were placed in the para position. Photocatalytic studies were performed in the presence of an iridium complex as a chromophore and have shown that [FeIII(TF4TMAP)](CF3SO3)5 can effectively reduce CO2, achieving excellent turnover numbers (up to 5500 TONs) and high turnover frequencies. The main reduction product of this photocatalytic system was CO, and only a small amount of hydrogen was detected, presenting a maximum selectivity of 86 % for CO.
The Cover Feature depicts the photocatalytic CO2 reduction using for the first time the iron porphyrin derivative [FeIII(TF4TMAP)](CF3SO3)5 as molecular catalyst. In their Research Article, M. Orio, G. Charalambidis, A. G. Coutsolelos and co‐workers demonstrate that after light irradiation, CO2 to CO conversion was observed, achieving excellent turnover numbers (up to 5500 TONs) and high selectivity. More information can be found in the Research Article by M. Orio, G. Charalambidis, A. G. Coutsolelos and co‐workers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.